Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hangzhou Alltest Biotech CoSHSE:688606 +1.19%53 Shareholder Yield % is 4.78% as of Mar. 2026, which is 24% above its 10-year median of 3.87. GuruFocus rates SHSE:688606 with a GF Score™ of 53/100 and a GF Value™ of ¥85.74 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Hangzhou Alltest Biotech Co ranks better than 82.92% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Hangzhou Alltest Biotech Co's Shareholder Yield % was 4.78%.
Hangzhou Alltest Biotech Co (SHSE:688606) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Hangzhou Alltest Biotech Co Shareholder Yield % Related Terms
Hangzhou Alltest Biotech Co Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Alltest Biotech Co Shareholder Yield % Chart
SHSE:688606 vs ISRG, BDX, MDLN: Shareholder Yield % Comparison
For the Medical Instruments & Supplies subindustry, Hangzhou Alltest Biotech Co's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Alltest Biotech Co Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou Alltest Biotech Co's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Hangzhou Alltest Biotech Co's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Hangzhou Alltest Biotech Co (SHSE:688606) has a Shareholder Yield % of 4.78% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Hangzhou Alltest Biotech Co and its competitors. This is 24% above median its historical median of 3.87. Over the past decade, Hangzhou Alltest Biotech Co's Shareholder Yield % has ranged from 0.91 to 13.17. According to the industry distribution chart, Hangzhou Alltest Biotech Co ranks #139 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 17.1%.
Is Hangzhou Alltest Biotech Co's Shareholder Yield % too high?
Hangzhou Alltest Biotech Co's current Shareholder Yield % of 4.78% is 24% above median its 10-year median of 3.87. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 13.17. The Medical Devices & Instruments industry median Shareholder Yield % is 0.16. Hangzhou Alltest Biotech Co's value of 4.78% is 2887.5% above this industry median. Based on the distribution chart, Hangzhou Alltest Biotech Co ranks #139 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hangzhou Alltest Biotech Co has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Alltest Biotech Co's Shareholder Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hangzhou Alltest Biotech Co ranks #139 out of 814 companies for Shareholder Yield %. This places Hangzhou Alltest Biotech Co in the top 17% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.16. Hangzhou Alltest Biotech Co's value of 4.78% is 2887.5% above this benchmark. Historically, Hangzhou Alltest Biotech Co's own Shareholder Yield % has ranged from 0.91 to 13.17 over the past decade. While the company's 10-year median is 3.87 vs. the industry median of 0.16, Hangzhou Alltest Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.16, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou Alltest Biotech Co's current Shareholder Yield % of 4.78% is 2887.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Hangzhou Alltest Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Alltest Biotech Co's current Shareholder Yield % is 4.78%, which is 24% above median its own 10-year median of 3.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Alltest Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Alltest Biotech Co (SHSE:688606) is currently considered Possible Value Trap. The stock's GF Value™ is ¥85.74, compared to a current price of ¥43.47 — trading 49.3% below its estimated fair value. The current Shareholder Yield % is 4.78%, which is 24% above median its 10-year median of 3.87 and 2887.5% above the Medical Devices & Instruments industry median of 0.16. Hangzhou Alltest Biotech Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Hangzhou Alltest Biotech Co (SHSE:688606), the current Shareholder Yield % is 4.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Alltest Biotech Co (SHSE:688606) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Alltest Biotech Co stock appears to be undervalued.
The current stock price of ¥43.47 is trading 49.3% below its estimated GF Value™ of ¥85.74.
GuruFocus considers Hangzhou Alltest Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688606:
Shareholder Yield %: 4.78% (24% above median its 10-year median of 3.87)
GF Value™: ¥85.74 vs. price of ¥43.47 (49.3% below fair value)
Industry Position: 2887.5% above the Medical Devices & Instruments median (#139 of 814)
No single metric tells the full story. See the SHSE:688606 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688606 has been successfully added to your 
